Navigation Links
Express Scripts Recommends Rejection of TRC Capital's "Mini-Tender" Offer
Date:4/9/2013

ST. LOUIS, April 9, 2013 /PRNewswire/ -- Express Scripts Holding Company ("Express Scripts") (NASDAQ: ESRX) today announced that it has been notified of an unsolicited "mini-tender" offer by TRC Capital Corporation to purchase up to 2 million shares of Express Scripts common stock, or approximately 0.24 percent of shares outstanding, at $55.75 per share, which is approximately 2.7 percent below the closing share price of Express Scripts common stock on April 8, 2013 ($57.27).

Express Scripts does not endorse TRC Capital's offer and recommends that Express Scripts stockholders reject the offer and not tender their shares in response to TRC Capital's unsolicited mini-tender offer. Express Scripts is not associated in any way with TRC Capital, its mini-tender offer or the offer documentation.

This mini-tender offer is at a price below the current market price and is subject to numerous conditions.  Express Scripts urges investors to obtain current market quotations for their shares, review the conditions to the offer, consult with their broker or financial advisor and exercise caution with respect to TRC Capital's mini-tender offer.

Express Scripts stockholders who have already tendered are advised that, as described in TRC Capital's Offer to Purchase document, they may withdraw their shares prior to the expiration of the offer, which is currently scheduled at 12:01 a.m. Eastern time on Thursday, May 2, 2013, unless extended.

TRC Capital has made similar, unsolicited mini-tender offers for shares of other publicly-traded companies.  Mini-tender offers are designed to seek to acquire less than 5 percent of a company's outstanding shares, thereby avoiding many disclosure and procedural requirements of the Securities and Exchange Commission that apply to tender offers for more than 5 percent of a company's outstanding shares.  As a result, mini-tender offers do not provide investors with the same level of protections as provided by larger tender offers under United States securities laws.

On its website, the SEC states that mini-tender offers "have been increasingly used to catch investors off guard. Many investors who hear about mini-tender offers surrender their securities without investigating the offer, assuming that the price offered includes the premium usually present in larger, traditional tender offers. But they later learn that they cannot withdraw from the offer and may end up selling their securities at below-market prices."

For more information about mini-tenders, please visit the SEC website at: http://www.sec.gov/answers/miniten.htm

Express Scripts encourages brokers and dealers, as well as other market participants, to review the SEC's letter regarding broker-dealer mini-tender offer dissemination and disclosures at: www.sec.gov/divisions/marketreg/minitenders/sia072401.htm and the NASD Notice to Members 99-53 issued in July 1999, regarding guidance to members forwarding mini-tender offers to their customers, which can be found at: http://www.finra.org/web/groups/industry/@ip/@reg/@notice/documents/notices/p004221.pdf

Express Scripts requests that a copy of this press release be included with all distributions of materials relating to TRC Capital's offer.

About Express Scripts

Express Scripts manages more than a billion prescriptions each year for tens of millions of people. On behalf of our clients — employers, health plans, unions and government health programs — we make the use of prescription drugs safer and more affordable. We innovate to enhance patient care, reduce pharmacy-related waste and increase therapy adherence. Building on a strong clinical foundation, we apply our understanding of the behavioral sciences — an approach we call Consumerology® — to make it easier for people to choose better health.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

 


'/>"/>
SOURCE Express Scripts, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Express Scripts Study Reveals Keys to Controlling Specialty Drug Costs
2. Express Scripts to Present at Upcoming Conferences
3. Generex Touts Pipeline Potential of Antigen Express Subsidiary
4. Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
5. FCS Express Compatible with Life Technologies Tali Image Based Cytometer
6. Express Scripts Holding Company Announces Fourth Quarter 2012 Earnings Conference Call
7. Suture Express Files Antitrust Lawsuit Against Cardinal Health and Owens & Minor
8. Express Scripts Publishes Inaugural Drug Trend Quarterly, Provides First Comprehensive Overview of U.S. Prescription Drug Spending for 2012
9. Express Scripts Reports Third Quarter Results
10. The Growing Cost of Aging: Express Scripts Study Shows Medication Use for Normal Aging Conditions Overtakes Costs of Treating Most Chronic Diseases
11. Express Scripts Launches Virtual Coaching To Help Patients Better Understand Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Acute Ischemic ... 2016"  report to their offering.  ... Global Acute Ischemic Stroke Market ... insights into Acute Ischemic Stroke pipeline products, ...
(Date:5/3/2016)... 3, 2016 BioNovus Innovations LLC and ... Advancing Medical Innovation (IAMI) today announced a new ... and medical devices. An agreement between ... to license, develop and commercialize medical innovations advanced ... "This partnership represents a significant advance in our ...
(Date:5/3/2016)... May 3, 2016   BIOTRONIK , a ... announced Food and Drug Administration (FDA) approval of ... provides heart failure patients with access to diagnostic ... have remote monitoring with daily automatic transmission and ... rate in response to physiological demands. ...
Breaking Medicine Technology:
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... Behavioral Health Population Management Platform, announced today that Enlightened Solutions has joined the ... ability to optimize the care continuum for their patients being treated for substance ...
(Date:5/5/2016)... ... ... Liposuction specialist Marcia V. Byrd, MD spoke last month at the Fat ... Louis Airport Hotel. This year’s conference was titled “Living with Lipedema and Dealing with ... in treating Lipedema. Dr. Byrd is considered one of the leading physicians in the ...
(Date:5/5/2016)... ... 2016 , ... Nepenthe Laboratory Services (NLS), a premier drug monitoring and toxicology ... food item donations for Food for Lane County, and to help support awareness for ... of the assembly was to create an exciting atmosphere for the kids at Riverbend ...
(Date:5/5/2016)... Augusta, Kansas (PRWEB) , ... May 05, 2016 , ... ... management for its school nurses. This partnership will enable school health offices to streamline ... located in Butler County, Kansas, just east of Wichita. Augusta public schools serve 2,300 ...
(Date:5/5/2016)... ... May 05, 2016 , ... In an effort to ... a public health promotion and research organization, declared May as “National Sunshine Month.” ... other shifts in cultural behavior over the past several decades, Americans spend more ...
Breaking Medicine News(10 mins):